Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting
- 1 July 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (7) , 21-28
- https://doi.org/10.1016/j.amjmed.2005.05.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaEuropean Respiratory Journal, 2003
- Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter studyDiagnostic Microbiology and Infectious Disease, 2002
- Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 2002
- A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumoniaClinical Therapeutics, 2002
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic SocietyClinical Infectious Diseases, 2000
- A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumoniaAntimicrobial Agents and Chemotherapy, 1997